• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

增强的树突状肌动蛋白网络形成在延伸的伪足中推动了 Rac1 黑素瘤细胞在生长受限情况下的增殖。

Enhanced Dendritic Actin Network Formation in Extended Lamellipodia Drives Proliferation in Growth-Challenged Rac1 Melanoma Cells.

机构信息

Lyda Hill Department of Bioinformatics, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA; Department of Cell Biology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.

Department of Cell Biology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.

出版信息

Dev Cell. 2019 May 6;49(3):444-460.e9. doi: 10.1016/j.devcel.2019.04.007.

DOI:10.1016/j.devcel.2019.04.007
PMID:31063759
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6760970/
Abstract

Actin assembly supplies the structural framework for cell morphology and migration. Beyond structure, this actin framework can also be engaged to drive biochemical signaling programs. Here, we describe how the hyperactivation of Rac1 via the P29S mutation (Rac1) in melanoma hijacks branched actin network assembly to coordinate proliferative cues that facilitate metastasis and drug resistance. Upon growth challenge, Rac1-harboring melanoma cells massively upregulate lamellipodia formation by dendritic actin polymerization. These extended lamellipodia form a signaling microdomain that sequesters and phospho-inactivates the tumor suppressor NF2/Merlin, driving Rac1 cell proliferation in growth suppressive conditions. These biochemically active lamellipodia require cell-substrate attachment but not focal adhesion assembly and drive proliferation independently of the ERK/MAPK pathway. These data suggest a critical link between cell morphology and cell signaling and reconcile the dichotomy of Rac1's regulation of both proliferation and actin assembly by revealing a mutual signaling axis wherein actin assembly drives proliferation in melanoma.

摘要

肌动蛋白组装为细胞形态和迁移提供了结构框架。除了结构,这个肌动蛋白框架还可以参与驱动生化信号程序。在这里,我们描述了黑色素瘤中通过 P29S 突变(Rac1)使 Rac1 过度激活如何劫持分支肌动蛋白网络组装,以协调促进转移和耐药性的增殖线索。在生长挑战下,携带 Rac1 的黑色素瘤细胞通过树突状肌动蛋白聚合大量地上调片状伪足形成。这些延伸的片状伪足形成一个信号微域,隔离并使肿瘤抑制因子 NF2/Merlin 磷酸化失活,在生长抑制条件下驱动 Rac1 细胞增殖。这些具有生物化学活性的片状伪足需要细胞-底物附着,但不需要焦点附着组装,并独立于 ERK/MAPK 途径驱动增殖。这些数据表明细胞形态和细胞信号之间存在关键联系,并通过揭示肌动蛋白组装在黑色素瘤中驱动增殖的相互信号轴,调和了 Rac1 对增殖和肌动蛋白组装的调节的二分法。

相似文献

1
Enhanced Dendritic Actin Network Formation in Extended Lamellipodia Drives Proliferation in Growth-Challenged Rac1 Melanoma Cells.增强的树突状肌动蛋白网络形成在延伸的伪足中推动了 Rac1 黑素瘤细胞在生长受限情况下的增殖。
Dev Cell. 2019 May 6;49(3):444-460.e9. doi: 10.1016/j.devcel.2019.04.007.
2
RAC1 Induces a Mesenchymal Phenotypic Switch via Serum Response Factor to Promote Melanoma Development and Therapy Resistance.RAC1 通过血清反应因子诱导间充质表型转换,促进黑色素瘤的发展和治疗耐药性。
Cancer Cell. 2019 Jul 8;36(1):68-83.e9. doi: 10.1016/j.ccell.2019.05.015. Epub 2019 Jun 27.
3
14-3-3beta-Rac1-p21 activated kinase signaling regulates Akt1-mediated cytoskeletal organization, lamellipodia formation and fibronectin matrix assembly.14-3-3β-Rac1-p21激活激酶信号传导调节Akt1介导的细胞骨架组织、板状伪足形成和纤连蛋白基质组装。
J Cell Physiol. 2009 Feb;218(2):394-404. doi: 10.1002/jcp.21612.
4
RAC1 P29S regulates PD-L1 expression in melanoma.RAC1 P29S调节黑色素瘤中程序性死亡受体配体1(PD-L1)的表达。
Pigment Cell Melanoma Res. 2015 Sep;28(5):590-8. doi: 10.1111/pcmr.12392.
5
RAC1mutation is not a predictive biomarker for PI3'-kinase-β-selective pathway-targeted therapy.RAC1 突变不是 PI3′-激酶-β 选择性通路靶向治疗的预测性生物标志物。
Pigment Cell Melanoma Res. 2020 Sep;33(5):719-730. doi: 10.1111/pcmr.12889. Epub 2020 May 28.
6
Suppression of RAC1-driven malignant melanoma by group A PAK inhibitors.A 组 PAK 抑制剂抑制 RAC1 驱动的恶性黑色素瘤。
Oncogene. 2018 Feb 15;37(7):944-952. doi: 10.1038/onc.2017.400. Epub 2017 Oct 23.
7
Mechanistic Differences of Activation of Rac1 and Rac1.Rac1激活的机制差异与Rac1。 (注:原文中“Mechanistic Differences of Activation of Rac1 and Rac1”表述似乎有误,正常应该是不同物质激活Rac1的机制差异等意思,但按要求直接翻译了。)
J Phys Chem B. 2021 Apr 22;125(15):3790-3802. doi: 10.1021/acs.jpcb.1c00883. Epub 2021 Apr 13.
8
Fermitin family member 2 promotes melanoma progression by enhancing the binding of p-α-Pix to Rac1 to activate the MAPK pathway.FERMT2 通过增强 p-α-Pix 与 Rac1 的结合来激活 MAPK 通路,从而促进黑色素瘤的进展。
Oncogene. 2021 Sep;40(37):5626-5638. doi: 10.1038/s41388-021-01954-8. Epub 2021 Jul 28.
9
Unique vulnerability of RAC1-mutant melanoma to combined inhibition of CDK9 and immune checkpoints.RAC1 突变型黑色素瘤对 CDK9 与免疫检查点联合抑制的独特易损性。
Oncogene. 2024 Mar;43(10):729-743. doi: 10.1038/s41388-024-02947-z. Epub 2024 Jan 19.
10
Sra-1 and Nap1 link Rac to actin assembly driving lamellipodia formation.Sra-1和Nap1将Rac与驱动片状伪足形成的肌动蛋白组装相连接。
EMBO J. 2004 Feb 25;23(4):749-59. doi: 10.1038/sj.emboj.7600084. Epub 2004 Feb 5.

引用本文的文献

1
Elevated SNHG1 promotes invasion and migration of Cd(II)-transformed cells through Sox2, Rac1, and Slug.升高的SNHG1通过Sox2、Rac1和Slug促进镉(II)转化细胞的侵袭和迁移。
Toxicol Appl Pharmacol. 2025 Sep;502:117452. doi: 10.1016/j.taap.2025.117452. Epub 2025 Jun 24.
2
Direct Arp2/3-vinculin binding is required for pseudopod extension, but only on compliant substrates and in 3D.伪足延伸需要Arp2/3与纽蛋白直接结合,但仅在顺应性底物上和三维环境中才需要。
iScience. 2025 May 9;28(6):112623. doi: 10.1016/j.isci.2025.112623. eCollection 2025 Jun 20.
3
Morphological control of merlin-Rac antagonism in proliferation-promoting signaling.

本文引用的文献

1
Cell shape information is transduced through tension-independent mechanisms.细胞形状信息通过不依赖张力的机制进行转导。
Nat Commun. 2017 Dec 15;8(1):2145. doi: 10.1038/s41467-017-02218-4.
2
Suppression of RAC1-driven malignant melanoma by group A PAK inhibitors.A 组 PAK 抑制剂抑制 RAC1 驱动的恶性黑色素瘤。
Oncogene. 2018 Feb 15;37(7):944-952. doi: 10.1038/onc.2017.400. Epub 2017 Oct 23.
3
PAK signalling drives acquired drug resistance to MAPK inhibitors in BRAF-mutant melanomas.PAK信号传导驱动BRAF突变型黑色素瘤对MAPK抑制剂产生获得性耐药。
促进增殖信号通路中默林-Rac拮抗作用的形态学调控
Sci Signal. 2025 May 20;18(887):eadk0922. doi: 10.1126/scisignal.adk0922.
4
Autonomous learning of pathologists' cancer grading rules.病理学家癌症分级规则的自主学习
bioRxiv. 2025 Apr 7:2025.03.18.643999. doi: 10.1101/2025.03.18.643999.
5
Vimentin filament transport and organization revealed by single-particle tracking and 3D FIB-SEM.通过单粒子追踪和3D聚焦离子束扫描电子显微镜揭示波形蛋白丝的运输与组织
J Cell Biol. 2025 Apr 7;224(4). doi: 10.1083/jcb.202406054. Epub 2025 Mar 10.
6
Identification of LIMK1 as a biomarker in clear cell renal cell carcinoma: from data mining to validation.鉴定LIMK1作为透明细胞肾细胞癌的生物标志物:从数据挖掘到验证。
J Cancer Res Clin Oncol. 2025 Mar 8;151(3):104. doi: 10.1007/s00432-025-06146-5.
7
Role of Hypoxia and Rac1 Inhibition in the Metastatic Cascade.缺氧和Rac1抑制在转移级联反应中的作用。
Cancers (Basel). 2024 May 14;16(10):1872. doi: 10.3390/cancers16101872.
8
Universal consensus 3D segmentation of cells from 2D segmented stacks.从二维分割堆栈中对细胞进行通用一致的三维分割。
bioRxiv. 2025 Mar 20:2024.05.03.592249. doi: 10.1101/2024.05.03.592249.
9
Rac1 promotes kidney collecting duct repair by mechanically coupling cell morphology to mitotic entry.Rac1 通过机械偶联细胞形态与有丝分裂进入来促进肾集合管修复。
Sci Adv. 2024 Feb 9;10(6):eadi7840. doi: 10.1126/sciadv.adi7840. Epub 2024 Feb 7.
10
RhoA activation promotes glucose uptake to elevate proliferation in MAPK inhibitor resistant melanoma cells.RhoA激活促进葡萄糖摄取,以提高对MAPK抑制剂耐药的黑色素瘤细胞的增殖能力。
bioRxiv. 2024 Jan 11:2024.01.09.574940. doi: 10.1101/2024.01.09.574940.
Nature. 2017 Oct 5;550(7674):133-136. doi: 10.1038/nature24040. Epub 2017 Sep 27.
4
Load Adaptation of Lamellipodial Actin Networks.片状伪足肌动蛋白网络的负载适应
Cell. 2017 Sep 21;171(1):188-200.e16. doi: 10.1016/j.cell.2017.07.051. Epub 2017 Aug 31.
5
The Rac GTPase in Cancer: From Old Concepts to New Paradigms.癌症中的Rac GTP酶:从旧概念到新范式
Cancer Res. 2017 Oct 15;77(20):5445-5451. doi: 10.1158/0008-5472.CAN-17-1456. Epub 2017 Aug 14.
6
Matrix stiffening promotes a tumor vasculature phenotype.基质硬化促进肿瘤血管表型。
Proc Natl Acad Sci U S A. 2017 Jan 17;114(3):492-497. doi: 10.1073/pnas.1613855114. Epub 2016 Dec 29.
7
Molecular Pathways: Maintaining MAPK Inhibitor Sensitivity by Targeting Nonmutational Tolerance.分子途径:通过靶向非突变耐受性维持丝裂原活化蛋白激酶(MAPK)抑制剂敏感性
Clin Cancer Res. 2016 Dec 15;22(24):5966-5970. doi: 10.1158/1078-0432.CCR-16-0954. Epub 2016 Oct 19.
8
Rho GTPases, their post-translational modifications, disease-associated mutations and pharmacological inhibitors.Rho 小 G 蛋白、其翻译后修饰、疾病相关突变及药理抑制剂。
Small GTPases. 2018 May 4;9(3):203-215. doi: 10.1080/21541248.2016.1218407. Epub 2016 Aug 22.
9
ERK/MAPK Signaling Drives Overexpression of the Rac-GEF, PREX1, in BRAF- and NRAS-Mutant Melanoma.ERK/MAPK信号通路驱动Rac鸟苷酸交换因子PREX1在BRAF和NRAS突变型黑色素瘤中过表达。
Mol Cancer Res. 2016 Oct;14(10):1009-1018. doi: 10.1158/1541-7786.MCR-16-0184. Epub 2016 Jul 14.
10
GEFs: Dual regulation of Rac1 signaling.鸟嘌呤核苷酸交换因子(GEFs):Rac1信号的双重调控
Small GTPases. 2017 Apr 3;8(2):90-99. doi: 10.1080/21541248.2016.1202635. Epub 2016 Jun 17.